APA (7th ed.) Citation

ASMM, V., OA, C., T, C., C, S., JM, B., CG, F., . . . MEF, L. (2026). Structure-enabled enhancement of potency in a metronidazole-benznidazole hybrid: Design, synthesis, and evaluation of antitrypanosomal activity of a benzylamide-linked 5-nitroimidazole. Frontiers in pharmacology, 17, 1812023. https://doi.org/10.3389/fphar.2026.1812023

Chicago Style (17th ed.) Citation

ASMM, Velez, Chaves OA, Costa T, Serpa C, Borges JM, Freire-de-Lima CG, Decote-Ricardo D, and Lima MEF. "Structure-enabled Enhancement of Potency in a Metronidazole-benznidazole Hybrid: Design, Synthesis, and Evaluation of Antitrypanosomal Activity of a Benzylamide-linked 5-nitroimidazole." Frontiers in Pharmacology 17 (2026): 1812023. https://doi.org/10.3389/fphar.2026.1812023.

MLA (9th ed.) Citation

ASMM, Velez, et al. "Structure-enabled Enhancement of Potency in a Metronidazole-benznidazole Hybrid: Design, Synthesis, and Evaluation of Antitrypanosomal Activity of a Benzylamide-linked 5-nitroimidazole." Frontiers in Pharmacology, vol. 17, 2026, p. 1812023, https://doi.org/10.3389/fphar.2026.1812023.